Cite
HARVARD Citation
, . et al. (2022). Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Lancet oncology. 23 (3), pp. 382-392. [Online].